Lepu Medical Technology (Beijing) Co., Ltd.
300003
주식 순위
#4746
Established in 1999 and headquartered in Beijing, China, Lepu Medical... Established in 1999 and headquartered in Beijing, China, Lepu Medical Technology is a prominent company dedicated to the research, development, production, and sale of a broad spectrum of medical devices, pharmaceuticals, and healthcare services. The company's extensive medical device portfolio primarily focuses on cardiovascular health. This includes interventional cardiology products such as coronary stents, balloons, catheters, guide wires, and related PCI accessories. It also provides solutions for structural heart diseases, like occluders, vascular plugs, delivery systems, and mechanical heart valves. Lepu Medical offers cardiac rhythm management products, including pacemakers, equipment, leads, and electrophysiology systems, alongside products for off-pump coronary artery bypass grafting and peripheral interventional devices such as PTA balloons and guide wires. Beyond cardiovascular applications, their offerings extend to critical care products like vascular access devices, needle-free connectors, blood samplers, and pressure transducers. The company also provides digital subtraction angiography (DSA) systems (both floor and suspended types), in vitro diagnostic (IVD) equipment and biomarkers, hemodialysis catheters and hollow fiber dialyzers, and general surgery instruments including surgical staplers and endo surgery accessories. In the pharmaceutical sector, Lepu Medical manufactures and distributes medications for various conditions. This encompasses a comprehensive range of cardiovascular drugs designed to treat issues like thrombosis, hyperlipidemia, hypertension, angina, and heart failure. Additionally, they produce beta-lactamase antibiotics and antifungal antimicrobial drugs, central nervous system medications (such as painkillers and antidepressants), treatments for gastric/duodenal ulcers and chronic liver disease, respiratory system drugs, hypoproteinemia drugs, and agents that activate blood circulation. Furthermore, Lepu Medical provides a diverse array of healthcare services. These include precision medicine, remote ECG telemonitoring, and specialized consulting and management centers for cardiovascular diseases. The company is also involved in medical science and technology incubation, equity investment, and offers medical financial services. Its service offerings extend to general health consultation, online pharmacy platforms, sales of household medical equipment, smart medical devices, and the operation of specialized hospitals focusing on cardiovascular care. Lepu Medical actively participates in the establishment and co-construction of cardiac catheterization laboratories (Cath Labs).
주가
$1.78
시가총액
$3.15B
변동 (1일)
6.19%
변동 (1년)
-30.01%
국가
CN
거래 Lepu Medical Technology (Beijing) Co., Ltd. (300003)
카테고리
Healthcare
Lepu Medical Technology (Beijing) Co., Ltd. (300003)의 매출
Jun 2026 기준 매출 TTM: $916.95M
Lepu Medical Technology (Beijing) Co., Ltd.의 최신 재무 보고서에 따르면 회사의 현재 수익 (TTM)은 $916.95M입니다. 2023년에 회사는 $1.13B의 수익을 올렸으며 이는 2022년의 $1.54B 대비 감소입니다. 수익은 상품이나 서비스를 판매하여 얻은 총 수입을 의미합니다. 수익과는 달리 비용이 차감되지 않습니다.
Lepu Medical Technology (Beijing) Co., Ltd.의 수익 기록 (2006 ~ 2026)
매년 말 매출
| 연도 | 매출 | 변화 |
|---|---|---|
| 2026 (TTM) | $916.95M | 9.66% |
| 2024 | $836.17M | -25.83% |
| 2023 | $1.13B | -26.70% |
| 2022 | $1.54B | -8.29% |
| 2021 | $1.68B | 36.29% |
| 2020 | $1.23B | 9.92% |
| 2019 | $1.12B | 21.15% |
| 2018 | $924.07M | 32.50% |
| 2017 | $697.43M | 39.64% |
| 2016 | $499.47M | 17.15% |
| 2015 | $426.37M | 58.27% |
| 2014 | $269.40M | 25.38% |
| 2013 | $214.86M | 31.88% |
| 2012 | $162.92M | 12.92% |
| 2011 | $144.28M | 23.66% |
| 2010 | $116.67M | 40.93% |
| 2009 | $82.79M | 43.42% |
| 2008 | $57.72M | 40.97% |
| 2007 | $40.95M | 82.30% |
| 2006 | $22.46M | 0.00% |
유사 기업 또는 경쟁사의 매출
| 회사 | 매출 | 매출 차이 | 국가 |
|---|---|---|---|
| $46.59B | 4,980.44% |
US
|
|
| $35.48B | 3,769.79% |
IE
|
|
| $25.84B | 2,717.72% |
US
|
|
| $21.00B | 2,189.77% |
US
|
|
| - | - |
DE
|
